ETV5 Reduces Androgen Receptor Expression and Induces Neural Stem-Like Properties during Neuroendocrine Prostate Cancer Development

By
Noshin Noorjahan
-
0
5
The authors explored the role of E26 transformation-specific variant 5 (ETV5) in neuroendocrine prostate cancer development. Analysis of multiple prostate cancer datasets revealed that NEPC was characterized by significantly elevated ETV5 expression compared to other subtypes.
[Proceedings of The National Academy of Sciences of The United States of America]
Abstract